CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,688,844 | -11.3% | 396,770 | -1.8% | 0.07% | -5.5% |
| Q2 2023 | $13,183,764 | -25.1% | 404,162 | -19.2% | 0.07% | -29.1% |
| Q1 2023 | $17,608,000 | -27.6% | 500,385 | -8.7% | 0.10% | -30.9% |
| Q4 2022 | $24,307,000 | -10.2% | 548,077 | -1.9% | 0.15% | -15.8% |
| Q3 2022 | $27,071,000 | +59.7% | 558,750 | +29.5% | 0.18% | +67.0% |
| Q2 2022 | $16,950,000 | +96.3% | 431,423 | +83.9% | 0.11% | +140.9% |
| Q1 2022 | $8,633,000 | – | 234,545 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |